Long-term observational data presented at the 2014 European Society of Retina Specialists (EURETINA) conference support the safety and efficacy profile of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab (Lucentis, Novartis) for the treatment of appropriate patients across its indications
Endoscopic cyclophotocoagulation (ECP) and phacoemulsification cataract extraction, when combined, result in greater reduction of IOP and need for IOP-lowering medications over 3 years compared with cataract extraction by itself.
CataRhex 3 ? Phaco without Limits Never before has cutting-edge technology for anterior segment surgery been as easily and reliably available, and never before has its packaging been more compact and tempting.
The European Commission has extended marketing authorization for an intravitreal implant with 700 mcg of dexamethasone in an applicator (Ozurdex, Allergan) for the treatment of adults with visual impairment caused by diabetic macular oedema (DME) who have pseudophakia or whose condition is considered insufficiently responsive to or unsuitable for non-corticosteroid therapy.
A video goggle-based technology may help increase visual acuity (VA) in children with amblyopia.
An international study led by King's College London has identified genetic links to glaucoma.
Dr Omid Kermani discusses his pre-ESCRS diary, highlighting what he believes will be the best bits from the packed programme.
Optimal resistance to in vitro keratolysis by collagenase A can be achieved by collagen crosslinking the deepithelialized anterior corneal surface for 30 minutes, according to a recently published study.
Intracameral cefuroxime can help prevent endophthalmitis after cataract surgery and does so cost-effectively, according to Spanish researchers who conducted a systematic literature review.
Align toric IOLs and skip the manual marking and data transfer steps with products designed to work together for markerless toric IOL alignment.
Severe obstructive sleep apnoea (OSA) is an important risk factor for developing glaucoma and must be treated in those who have it to improve control of the eye disease, according to new research.
In this article, comparative data is presented proving that trabeculectomy is more effective than non-penetrating options, however, does pose an increased risk of complications, leading to the conclusion that at the moment, procedures should be chosen on an individual basis.
Here, the author discusses the findings of a recent study examining the efficacy and safety of the Raindrop Near Vision Inlay in emmetropic presbyopes and then compares these with results from an unpublished study on patients with low hyperopia.
There have been few studies primarily concerned with the relative frequencies and clinical characteristics of cranial neuropathies in diabetic subjects. Here, Dr Stefanucci gives a synopsis of the clinical characteristics and risk factors.
The standard of care is implantation with an IOL, and with the introduction of a new lens to the European market, Dr Hamid and colleagues conducted a small trial to analyse the differences between this new option and other available lenses. Here, he presents his findings.
Products
In this article, Dr Conrad-Hengerer discusses a recent study investigating the impact of femtosecond laser-assisted surgery on anterior chamber flare values and macular thickness compared with standard phaco.
We at OTEurope, wanted to look back over the last 10 years at what has changed over the years. In such a fast-paced industry, there have been monumental strides forward since the launch of this publication.
Prof. Dick discusses the challenges posed by a small pupil in femtosecond laser cataract surgery and the options that are available to surgeons to overcome pupil constriction.
A small-aperture corneal inlay (Kamra, AcuFocus, Irvine, California, USA) for presbyopia yielded superb results in an analysis of long-term data.
Controversy continues over whether the femtosecond laser provides advantages in cataract surgery that justify its added cost.
In a recent satellite symposium, sponsored by Bayer, the topic of macular oedema following CRVO was discussed by a panel of experts. Here, we present a summary of this meeting, highlighting the key outcomes.
Studies with follow-up of 2 to 6 years show that corneal crosslinking for progressive keratectasia is safe and induces long-term structural changes.
The international sight-saving charity Orbis has launched an appeal to help eliminate avoidable blindness in Ethiopia.
Become a witness when Oertli is launching their new anterior and vitreoretinal surgery platform and experience another international sensation made in Switzerland.
KalVista Pharmaceuticals has begun a Phase I trial of its plasma kallikrein inhibitor KVD001 for the treatment of diabetic macular oedema (DME).
Advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness, according to a study recently published online.
Researchers examining age-related changes in heparan sulphate (HS) quantity and composition in human Bruch's membrane (BrM) have discovered that the quantity greatly decreases with age, resulting in fewer binding sites for complement factor H (CFH) and affecting the ability of the 402H variant of CFH to bind BrM.
A home-based treatment of amblyopia that incorporated an iPad quickly resulted in improved visual acuity (VA) in the children in whom it was tested, and VA remained stable for at least 3 months after the treatment ended, according to research published online.
European Association for Vision and Eye Research, EVER is the leading ophthalmological research association in Europe which covers all areas of ophthalmology and the visual sciences.